FDA Approves Rexulti For Agitation Associated With Dementia Due To Alzheimer's

The U.S. Food and Drug Administration announced the supplemental approval of Rexulti (brexpiprazole) oral tablets to treat agitation associated with dementia due to Alzheimer's disease.
The U.S. Food and Drug Administration announced the supplemental approval of Rexulti (brexpiprazole) oral tablets to treat agitation associated with dementia due to Alzheimer's disease.

Mark Oldham on X: I had no clue they were going for this indication! I need to read more about this. #Brexpiprazole is similar to aripiprazole, which is among the most prescribed

What is agitation that may happen with dementia due to Alzheimer's disease?

Otsuka, Lundbeck's Rexulti nabs new use in Alzheimer's disease agitation

Deborah Dunsire: Rexulti in agitation could potentially outperform blockbuster sales — MedWatch

FDA OKs First Drug for Agitation in Alzheimer's Dementia

Articles about Otsuka America Pharmaceutical, Inc.

REXULTI® (brexpiprazole) Agitation associated with dementia due to Alzheimer's disease

FDA approves first drug to treat agitation symptoms associated with dementia due to Alzheimer's disease

FDA Approves First-Ever Drug for Agitation Associated with Alzheimer's Dementia

FDA approves Rexulti for dementia patients dealing with agitation

FDA Approves First Drug Meant to Ease Alzheimer Disease-Linked Agitation - Southern Iowa Mental Health Center

Ask the Pharmacist: New drug treats Alzheimer's agitation, Health

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation